title: Risky-drugs list in the spotlight. Healthcare groups, drugmakers push for changes to improve safety.
authors: Shawn
authors: S
authors: Rhea
mesh_terms: D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D010344:Patient Advocacy; D014342:Truth Disclosure; D014481:United States; D014486:United States Food and Drug Administration